Arvinas
Develops PROTAC degraders around VEPPANU and clinical oncology, neurology, and neuromuscular programs.
$9.18
After-hours close+0.00 (+0.05%)
At close$9.18(−0.70%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 87.60%56.52M sharesInsiders 3.71%2.40M sharesOther 8.69%5.61M shares
Shares outstanding 64.52M · Float 55.87M · 86.6% free float
Institutions13F, as of Jun 30, 2026
205 holders · 56.52M shares · 37 new positions · 117 increased · 50 reduced · 43 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 7.61M | 11.79% | +811.5K | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 4.12M | 6.39% | +233.8K | Aug 13, 2026 |
| D. E. Shaw & Co., Inc. | 3.50M | 5.42% | −143.4K | Aug 14, 2026 |
| Pfizer Inc | 3.46M | 5.36% | 0 | Aug 13, 2026 |
| Armistice Capital, LLC | 2.80M | 4.33% | +818.0K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 2.71M | 4.21% | +24.8K | Aug 13, 2026 |
| Two Sigma Investments, LP | 2.57M | 3.99% | +741.3K | Aug 14, 2026 |
| State Street Corp | 2.20M | 3.40% | +368.4K | Aug 7, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 7.90% | 5.42M | 13G | Apr 17, 2025 ↗ |
| Vanguard Portfolio Management | 6.12% | 3.92M | 13G | Apr 28, 2026 ↗ |
| D. E. Shaw & Co., L.P. | 5.30% | 3.41M | 13G | Nov 14, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| John G. Houston | director | 1.12M | 1.74% | Mar 2, 2026 |
| Randy Teel | director, officer: President and CEO | 285.0K | 0.44% | May 22, 2026 |
| Noah Berkowitz | officer: Chief Medical Officer | 191.4K | 0.30% | May 13, 2026 |
| Andrew Saik | officer: Chief Financial Officer | 187.4K | 0.29% | Jun 24, 2026 |
| Angela M. Cacace | officer: Chief Scientific Officer | 180.4K | 0.28% | Jun 18, 2026 |
| Briggs Morrison | director | 111.5K | 0.17% | Jun 26, 2026 |
| Edward Moore Jr. Kennedy | director | 55.0K | 0.09% | Jun 26, 2026 |
| Linda Bain | director | 41.6K | 0.06% | Jun 26, 2026 |
| Everett Cunningham | director | 41.6K | 0.06% | Jun 26, 2026 |
| Leslie V. Norwalk | director | 41.6K | 0.06% | Jun 26, 2026 |
8 ten-percent owners hold 8.17M shares by Form 4, outside the officers-and-directors figure above · 10 people have not refiled in the last 18 months (2.58M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 24, 2026 | Andrew Saikofficer: Chief Financial Officer | Sale | 5,696 | $8.16 | 187,432 |
| Jun 17, 2026 | Angela M. Cacaceofficer: Chief Scientific Officer | Sale | 2,576 | $7.60 | 180,390 |
| May 21, 2026 | Randy Teeldirector, officer: President and CEO | Sale | 2,209 | $9.04 | 285,009 |
| May 11, 2026 | Randy Teeldirector, officer: President and CEO | Sale | 9,657 | $9.94 | 287,218 |
| May 11, 2026 | Noah Berkowitzofficer: Chief Medical Officer | Sale | 11,108 | $9.94 | 191,395 |
| May 11, 2026 | Angela M. Cacaceofficer: Chief Scientific Officer | Sale | 9,657 | $9.94 | 182,966 |
| May 11, 2026 | David K. Loomisofficer: VP, Chief Accounting Officer | Sale | 1,919 | $9.94 | 40,193 |
| May 11, 2026 | Andrew Saikofficer: Chief Financial Officer | Sale | 11,139 | $9.94 | 193,128 |
| Mar 18, 2026 | Noah Berkowitzofficer: Chief Medical Officer | Sale | 6,435 | $11.10 | 202,503 |
| Mar 6, 2026 | Briggs Morrisondirector | Purchase | 20,000 | $13.40 | 96,021 |
CongressHouse and Senate disclosures
Not reported.